Human Genome Epidemiology Literature Finder
|
Records 1 - 20 (of 20 Records) |
| Query Trace: Disease and meta-analysis and KRAS[original query] |
|---|
| Anti-epidermal growth factor receptor monoclonal antibody-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of PIK3CA mutations in KRAS wild-type patients. Archives of medical science : AMS 2014 Feb 10 (1): 1-9. Huang Lulu, Liu Zhenfang, Deng Donghong, Tan Aihua, Liao Ming, Mo Zengnan, Yang Xiao |
| KRAS Mutation as a Biomarker for Survival in Patients with Non-Small Cell Lung Cancer, A Meta-Analysis of 12 Randomized Trials. Asian Pacific journal of cancer prevention : APJCP 2015 16 (10): 4439-45. Ying Min, Zhu Xiao-Xia, Zhao Yang, Li Dian-He, Chen Long-H |
| KRAS mutation is a weak, but valid predictor for poor prognosis and treatment outcomes in NSCLC: A meta-analysis of 41 studies. Oncotarget 2016 Jan . Pan Wei, Yang Yan, Zhu Hongcheng, Zhang Youcheng, Zhou Rongping, Sun Xinch |
| Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers. Lung cancer (Amsterdam, Netherlands) 2016 Dec 102 122-134. Chapman Aaron M, Sun Kathie Y, Ruestow Peter, Cowan Dallas M, Madl Amy |
| The impact of primary tumor location on efficacy of cetuximab in metastatic colorectal cancer patients with different Kras status: a systematic review and meta-analysis. Oncotarget 2017 (32): 53631-53641. Cao De-Dong, Xu Hui-Lin, Xu Xi-Ming, Ge W |
| Clinicopathological Significance of Micropapillary Pattern in Lung Adenocarcinoma. Pathology oncology research : POR 2017 Jul . Pyo Jung-Soo, Kim Joo He |
| KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis. Oncotarget 2017 Jan . Du Lijun, Kim John J, Shen Jinhua, Chen Binrui, Dai Ni |
| Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis. Cancer management and research 2018 9 10 3393-3404. Zhang Shi-Ming, Zhu Qing-Ge, Ding Xiao-Xiao, Lin Song, Zhao Jing, Guan Lei, Li Ting, He Bing, Zhang Hu-Q |
| Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis. Cancer management and research 2018 10 2915-2924. Chen Duke, Wu Yu-Shen, Lin Huapeng, Wang Yihan, Li Longhao, Zhang T |
| PIK3CA mutation and clinicopathological features of colorectal cancer: a systematic review and Meta-Analysis. Acta oncologica (Stockholm, Sweden) 2019 9 59 (1): 66-74. Jin Juan, Shi Yaqin, Zhang Shu, Yang Shuof |
| Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis. Cancer medicine 2019 Dec . Bylsma Lauren C, Gillezeau Christina, Garawin Tamer A, Kelsh Michael A, Fryzek Jon P, Sangaré Laura, Lowe Kimberly |
| Comparison of efficacy and safety for patients with beyond second line treated metastatic colorectal cancer: a network meta-analysis of randomized controlled trials. Journal of chemotherapy (Florence, Italy) 2020 2 32 (4): 163-170. Cao Meihui, Zhou Mingyi, Zhang Jingdo |
| Reevaluating the prognostic role of BRAF mutation in colorectal cancer liver metastases. American journal of surgery 2021 Sep . Pikouli Anastasia, Papaconstantinou Dimitrios, Wang Jane, Kavezou Foteini, Pararas Nikolaos, Nastos Constantinos, Pikoulis Emmanouil, Margonis Georgios Antoni |
| Reevaluating the prognostic value of RAS mutation status in patients with resected liver metastases from colorectal cancer: A systematic review and meta-analysis. Journal of hepato-biliary-pancreatic sciences 2021 Jun . Pikoulis Emmanouil, Papaconstantinou Dimitrios, Pikouli Anastasia, Wang Jane, Theodoridis Charalampos, Margonis Georgios Antoni |
| KRAS mutation is predictive for poor prognosis in rectal cancer patients with neoadjuvant chemoradiotherapy: a systemic review and meta-analysis. International journal of colorectal disease 2021 3 36 (8): 1781-1790. Peng Junfu, Lv Jun, Peng Jishe |
| Efficacy of immune checkpoint inhibitors in the treatment of non-small cell lung cancer patients with different genes mutation: A meta-analysis. Medicine 2021 Mar 100 (10): e19713. Zhang Rui, Zhu Jing, Liu Ying, Xin Ying, Wang Ying, Niu Kai, Wei Huafa |
| Genetics and clinical phenotype of Erdheim-Chester disease: A case report of constrictive pericarditis and a systematic review of the literature. Frontiers in cardiovascular medicine 2022 9 876294. Bartoli Lorenzo, Angeli Francesco, Stefanizzi Andrea, Fabrizio Michele, Paolisso Pasquale, Bergamaschi Luca, Broccoli Alessandro, Zinzani Pier Luigi, Galiè Nazzareno, Rucci Paola, Foà Alberto, Pizzi Carmi |
| Efficacy and toxicity of drugs targeting KRAS mutation in non-small cell lung cancer: a meta-analysis. Expert review of anticancer therapy 2023 11 . Wei Luo, Jing Zhu, Wenxue Zhang, Airu Yu, Wei Zhou, Ke |
| Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Surgical oncology 2023 10 51 102007. Ali Alqahtani, Abdurahman Alloghbi, Philip Coffin, Chao Yin, Reetu Mukherji, Benjamin A Weinbe |
| Outcomes following KRAS inhibitor treatment in patients with KRAS-mutated solid tumors: A systematic review and meta-analysis. Pharmacological research 2024 1 200 107060. Qi-An Chen, Wei-Hao Lin, Xiao-Xiang Zhou, Zheng Cao, Xiao-Li Feng, Yi-Bo Gao, Jie |
- Page last reviewed:Feb 1, 2024
- Content source: